Načítá se...
ADHD Medication Use Following FDA Risk Warnings
BACKGROUND: In 2006, the U.S. Food and Drug Administration (FDA) investigated cardiac and psychiatric risks associated with attention deficit/hyperactivity disorder (ADHD) medication use. AIMS OF THE STUDY: To examine how disclosure of safety risks affected pediatric ADHD use, and to assess news med...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3896970/ https://ncbi.nlm.nih.gov/pubmed/23001280 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|